These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 15467034)

  • 81. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.
    Baran-Marszak F; Laguillier C; Youlyouz I; Feuillard J; Mariette X; Fagard R; Raphaël M
    Cytokine; 2006 Mar; 33(6):337-45. PubMed ID: 16713282
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
    Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M
    Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
    Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata.
    Son YO; Choi KC; Lee JC; Kook SH; Lee HJ; Jeon YM; Kim JG; Kim J; Lee WK; Jang YS
    J Cell Biochem; 2006 Dec; 99(5):1420-30. PubMed ID: 16817225
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
    Subklewe M; Sebelin K; Block A; Meier A; Roukens A; Paludan C; Fonteneau JF; Steinman RM; Münz C
    Hum Immunol; 2005 Sep; 66(9):938-49. PubMed ID: 16360833
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
    [TBL] [Abstract][Full Text] [Related]  

  • 87. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
    Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
    Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1.
    Henriquez NV; Floettmann E; Salmon M; Rowe M; Rickinson AB
    J Immunol; 1999 Mar; 162(6):3298-307. PubMed ID: 10092782
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The nitroreductase/CB1954 combination in Epstein-Barr virus-positive B-cell lines: induction of bystander killing in vitro and in vivo.
    Westphal EM; Ge J; Catchpole JR; Ford M; Kenney SC
    Cancer Gene Ther; 2000 Jan; 7(1):97-106. PubMed ID: 10678362
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells.
    Kim K; Ryu K; Ko Y; Park C
    Br J Haematol; 2005 Oct; 131(1):59-66. PubMed ID: 16173963
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
    Komano J; Takada K
    J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo.
    Sawa H; Murakami H; Kumagai M; Nakasato M; Yamauchi S; Matsuyama N; Tamura Y; Satone A; Ide W; Hashimoto I; Kamada H
    Acta Neuropathol; 2004 Jun; 107(6):523-31. PubMed ID: 15024582
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody.
    Piché A; Kasono K; Johanning F; Curiel TJ; Curiel DT
    Gene Ther; 1998 Sep; 5(9):1171-9. PubMed ID: 9930317
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 96. EBV latent membrane protein 1 is a negative regulator of TLR9.
    Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA
    J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.
    Iwata S; Saito T; Ito Y; Kamakura M; Gotoh K; Kawada J; Nishiyama Y; Kimura H
    Cancer Sci; 2012 Feb; 103(2):375-81. PubMed ID: 22017376
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
    Jilg W; Voltz R; Markert-Hahn C; Mairhofer H; Münz I; Wolf H
    Cancer Res; 1991 Jan; 51(1):27-32. PubMed ID: 1899042
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.
    Najjar I; Baran-Marszak F; Le Clorennec C; Laguillier C; Schischmanoff O; Youlyouz-Marfak I; Schlee M; Bornkamm GW; Raphaël M; Feuillard J; Fagard R
    J Virol; 2005 Apr; 79(8):4936-43. PubMed ID: 15795279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.